Mahixon S 250mg/125mg Injection
Marketer
Shreeji Healthcare Impex
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Mahixon S 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic indicated for treating diverse bacterial infections. Its mechanism combats microbial proliferation, thus curtailing infection spread. Administration must be solely under a physician's direction; strict adherence to the prescribed schedule is crucial. Complete the full course of treatment, regardless of symptom improvement, as premature cessation might compromise efficacy. Minor side effects may include nausea, vomiting, diarrhea, or dyspepsia. Report any worsening symptoms to your doctor immediately. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutritious food, and hydration are essential for optimal recovery. Your doctor may order laboratory tests to monitor treatment response.
Uses of Mahixon S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Mahixon S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mahixon S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Mahixon S 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Mahixon S 250mg/125mg Injection works:
Ceftriaxone/Sulbactam injection (Mahixon S 250mg/125mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's antibacterial action arises from its disruption of bacterial cell wall synthesis, vital for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Mahixon S 250mg/125mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Mahixon S (250mg/125mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful consequences to fetal development; nevertheless, research involving human subjects is currently scarce.
Breast feedingCAUTION
The administration of Mahixon S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Mahixon S 250mg/125mg Injection may induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving is contraindicated if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Mahixon S 250mg/125mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Caution is advised when administering Mahixon S 250mg/125mg Injection to individuals suffering from severe hepatic impairment; dosage modification may be necessary. A physician's consultation is recommended. Dosage alteration for Mahixon S 250mg/125mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Mahixon S 250mg/125mg Injection :
Omit a scheduled dose of Mahixon S 250mg/125mg Injection? Seek medical advice immediately.
Facts to Know About Mahixon S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently